Impairment of the glymphatic system after diabetes

Journal of Cerebral Blood Flow and Metabolism

Volumn 37, Issue 4, 2017, Pages 1326-1337

  Jiang, Quan ^a,b   Zhang, Li ^a   Ding, Guangliang ^a   Davoodi Bojd, Esmaeil ^a   Li, Qingjiang ^a   Li, Lian ^a   Sadry, Neema ^a   Nedergaard, Maiken ^c,d   Chopp, Michael ^a,b   Zhang, Zhenggang ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b OAKLAND UNIVERSITY   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cerebrospinal fluid interstitial fluid exchange; Cognitive deficits; Diabetes; Glymphatic system; Magnetic resonance imaging

Indexed keywords

GADOLINIUM PENTETATE; CONTRAST MEDIUM;

ANIMAL EXPERIMENT; ARTICLE; CEREBROSPINAL FLUID; CLEARANCE; CLUSTER ANALYSIS; COGNITIVE DEFECT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FLUORESCENCE IMAGING; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLYMPHATIC SYSTEM; HEMOLYMPHATIC SYSTEM; HIPPOCAMPUS; INTERSTITIAL FLUID; LATENT PERIOD; LEARNING; MALE; MEMORY; MORRIS WATER MAZE TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ODOR RECOGNITION TEST; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE; ANIMAL; BRAIN; DIAGNOSTIC IMAGING; EXPERIMENTAL DIABETES MELLITUS; EXTRACELLULAR FLUID; METABOLISM; PROCEDURES; WISTAR RAT;

ANIMALS; BRAIN; CEREBROSPINAL FLUID; CLUSTER ANALYSIS; CONTRAST MEDIA; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; EXTRACELLULAR FLUID; GADOLINIUM DTPA; MAGNETIC RESONANCE IMAGING; MALE; RATS, WISTAR;

EID: 85026298332     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X16654702     Document Type: Article

References (54)

1. Janghorbani M, Hu FB, Willett WC, et al. Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses’ Health Study. Diab Care 2007; 30: 1730-1735.
2. Giorda CB, Avogaro A, Maggini M, et al. Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. Stroke 2007; 38: 1154-1160.
3. Peila R, Rodriguez BL, White LR, et al. Fasting insulin and incident dementia in an elderly population of Japanese-American men. Neurology 2004; 63: 228-233.
4. Qiu C, Cotch MF, Sigurdsson S, et al. Retinal and cerebral microvascular signs and diabetes: the age, gene/ environment susceptibility-Reykjavik study. Diabetes 2008; 57: 1645-1650.
5. Luchsinger JA, Tang MX, Shea S, et al. Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004; 63: 1187-1192.
6. Craft S and Watson GS. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 2004; 3: 169-178.
7. Gispen WH and Biessels GJ. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 2000; 23: 542-549.
8. Luchsinger JA and Gustafson DR. Adiposity, type 2 diabetes, and Alzheimer’s disease. J Alzheimer Dis 2009; 16: 693-704.
9. Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science 2013; 342: 373-377.
10. Iliff JJ, Wang M, Zeppenfeld DM, et al. Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain. J Neurosci 2013; 33: 18190-18199.
11. Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 2012; 4: 147ra111.
12. Rangroo TV, Thrane AS, Plog BA, et al. Paravascular microcirculation facilitates rapid lipid transport and astrocyte signaling in the brain. Sci Rep 2013; 3: 2582.
13. Plog BA, Dashnaw ML, Hitomi E, et al. Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system. J Neurosci 2015; 35: 518-526.
14. Iliff JJ, Lee H, Yu M, et al. Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. J Clin Invest 2013; 123: 1299-1309.
15. Doubal FN, MacLullich AM, Ferguson KJ, et al. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke 2010; 41: 450-454.
16. Wardlaw JM, Smith C and Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 2013; 12: 483-497.
17. McCrimmon RJ, Ryan CM and Frier BM. Diabetes and cognitive dysfunction. Lancet 2012; 379: 2291-2299.
18. Moheet A, Mangia S and Seaquist ER. Impact of diabetes on cognitive function and brain structure. Ann N Y Acad Sci 2015; 1353: 60-71.
19. Mayeda ER, Whitmer RA and Yaffe K. Diabetes and cognition. Clin Geriat Med 2015; 31: 101-115.
20. Masiello P, Broca C, Gross R, et al. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998; 47: 224-229.
21. Su HC, Hung LM and Chen JK. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metabol 2006; 290: E1339-E1346.
22. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003; 46: 3-19.
23. Szkudelski T. Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Exp Biol Med 2012; 237: 481-490.
24. DeFronzo RA, Bonadonna RC and Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diab Care 1992; 15: 318-368.
25. Choi SH, Woodlee MT, Hong JJ, et al. A simple modification of the water maze test to enhance daily detection of spatial memory in rats and mice. J Neurosci Meth 2006; 156: 182-193.
26. Schallert T. Behavioral tests for preclinical intervention assessment. NeuroRx 2006; 3: 497-504.
27. Spinetta MJ, Woodlee MT, Feinberg LM, et al. Alcoholinduced retrograde memory impairment in rats: prevention by caffeine. Psychopharmacology 2008; 201: 361-371.
28. Fan X and Karczmar GS. A new approach to analysis of the impulse response function (IRF) in dynamic contrastenhanced MRI (DCEMRI): a simulation study. Magn Reson Med 2009; 62: 229-239.
29. Iliff JJ, Chen MJ, Plog BA, et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci 2014; 34: 16180-16193.
30. Lee H, Xie L, Yu M, et al. The effect of body posture on brain glymphatic transport. J Neurosci 2015; 35: 11034-11044.
31. Biessels GJ, Kamal A, Ramakers GM, et al. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes 1996; 45: 1259-1266.
32. Baydas G, Nedzvetskii VS, Nerush PA, et al. Altered expression of NCAM in hippocampus and cortex may underlie memory and learning deficits in rats with streptozotocin-induced diabetes mellitus. Life Sci 2003; 73: 1907-1916.
33. Hasanein P and Shahidi S. Effects of combined treatment with vitamins C and E on passive avoidance learning and memory in diabetic rats. Neurobiol Learn Memory 2010; 93: 472-478.
34. Eide PK and Ringstad G. MRI with intrathecal MRI gadolinium contrast medium administration: a possible method to assess glymphatic function in human brain. Acta Radiol Open 2015; 4: 2058460115609635.
35. Baglietto-Vargas D, Shi J, Yaeger DM, et al. Diabetes and Alzheimer’s disease crosstalk. Neurosci Biobehav Rev 2016; 64: 272-287.
36. Yaffe K, Blackwell T, Kanaya AM, et al. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004; 63: 658-663.
37. Qiu C, Sigurdsson S, Zhang Q, et al. Diabetes, markers of brain pathology and cognitive function: the Age, Gene/ Environment Susceptibility-Reykjavik Study. Ann Neurol 2014; 75: 138-146.
38. Prasad S, Sajja RK, Naik P, et al. Diabetes mellitus and blood-brain barrier dysfunction: an overview. J Pharmacovigil 2014; 2: 125.
39. Szeman B, Nagy G, Varga T, et al. [Changes in cognitive function in patients with diabetes mellitus]. Orvosi Hetilap 2012; 153: 323-329.
40. Janson J, Laedtke T, Parisi JE, et al. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 2004; 53: 474-481.
41. Ho L, Qin W, Pompl PN, et al. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease. FASEB J 2004; 18: 902-904.
42. Yang Y, Wu Y, Zhang S, et al. High glucose promotes Abeta production by inhibiting APP degradation. PloS One 2013; 8: e69824.
43. Vandal M, White PJ, Tremblay C, et al. Insulin reverses the high-fat diet-induced increase in brain Abeta and improves memory in an animal model of Alzheimer disease. Diabetes 2014; 63: 4291-4301.
44. Mehla J, Chauhan BC and Chauhan NB. Experimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficits. J Alzheimer Dis 2014; 39: 145-162.
45. Cao D, Lu H, Lewis TL, et al. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J Biol Chem 2007; 282: 36275-36282.
46. Wuerfel J, Haertle M, Waiczies H, et al. Perivascular spaces-MRI marker of inflammatory activity in the brain? Brain 2008; 131(Pt 9): 2332-2340.
47. Morton GJ and Schwartz MW. Leptin and the central nervous system control of glucose metabolism. Physiol Rev 2011; 91: 389-411.
48. Abizaid A and Horvath TL. Brain circuits regulating energy homeostasis. Regul Pept 2008; 149: 3-10.
49. Jackson CA, Hutchison A, Dennis MS, et al. Differing risk factor profiles of ischemic stroke subtypes: evidence for a distinct lacunar arteriopathy? Stroke 2010; 41: 624-629.
50. Giwa MO, Williams J, Elderfield K, et al. Neuropathologic evidence of endothelial changes in cerebral small vessel disease. Neurology 2012; 78: 167-174.
51. Rouhl RP, Damoiseaux JG, Lodder J, et al. Vascular inflammation in cerebral small vessel disease. Neurobiol Aging 2012; 33: 1800-1806.
52. Bailey EL, Smith C, Sudlow CL, et al. Pathology of lacunar ischemic stroke in humans-a systematic review. Brain Pathol 2012; 22: 583-591.
53. Hassan A, Hunt BJ, O’Sullivan M, et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003; 126(Pt 2): 424-432.
54. Fornage M, Chiang YA, O’Meara ES, et al. Biomarkers of inflammation and mri-defined small vessel disease of the brain: the cardiovascular health study. Stroke 2008; 39: 1952-1959.